World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR1614
Date of registration: 08/01/2009
Primary sponsor:
Public title: Injection with Botox in the anal sphicnter versus treatment with isosorbidedinitrate ointment for patients with an anal fissure. what is the most successful treatment?
Scientific title: Botulin Toxin versus Isosorbidedinitrate Ointment in Treatment Anal Fissure; A Prospective, Blinded, Randomized Trial. - N/A
Date of first enrolment: 1/6/2002
Target sample size: 86
Recruitment status: complete
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1614
Study type:  intervention
Study design:  Randomised: Yes; Masking: Double; Control: Placebo; Group: Parallel; Type: 2 or more arms, randomized  
Countries of recruitment
The Netherlands
Contacts
Name: S.  Festen
Address:  Onze Lieve Vrouwe Gasthuis, Oosterpark 9 Amsterdam The Netherlands
Telephone: +31 (0) 20 5999111
Email: s.festen@olvg.nl
Affiliation: 
Name: S.  Festen
Address:  Onze Lieve Vrouwe Gasthuis, Oosterpark 9 Amsterdam The Netherlands
Telephone: +31 (0) 20 5999111
Email: s.festen@olvg.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: All consecutive patients over the age of 18 with a chronic anal fissure presenting to our surgical outpatient clinic.
Exclusion criteria: 1. Pregnancy;

2. previous anal surgery;

3. Crohn?s disease;

4. systemic causes of an anal fissure.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Anal fissure

Intervention(s)
group I: Injection of 2x 10u botulin toxin in internal anal sphincter and application of placebo ointment 6 times daily.



group II: application of isosorbidedinitrate ointment 6 times daily and injection of placebo in internal anal sphincter.
Primary Outcome(s)
Macroscopic healing of the fissure at 4 months.
Secondary Outcome(s)
1. Fissure related pain;

2. treatment induced complications;

3. fissure recurrence;

4. costs.
Secondary ID(s)
31011972
Source(s) of Monetary Support
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history